# Cannabidiol for Bipolar Depression (CBD-BD)

> **NCT05867849** · PHASE3 · RECRUITING · sponsor: **University of British Columbia** · enrollment: 360 (estimated)

## Conditions studied

- Bipolar Disorder

## Interventions

- **DRUG:** Cannabidiol
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT05867849
- **Lead sponsor:** University of British Columbia
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-15
- **Primary completion:** 2029-12
- **Final completion:** 2030-12
- **Target enrollment:** 360 (ESTIMATED)
- **Last updated:** 2025-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05867849

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05867849, "Cannabidiol for Bipolar Depression (CBD-BD)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05867849. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*